The Science of the System: Biological Mechanisms and Subtypes
At a Glance
Autoinflammatory syndromes with immunodeficiency make the immune system both overactive and less able to fight infections: inflammation may continue without a germ while antibody production or other defenses are weak. Subtypes differ by the genetic change and whether it is inherited or acquired.
To understand these conditions, it helps to imagine the immune system as a complex security network with two main divisions: the innate system and the adaptive system. In a healthy person, these two branches communicate perfectly. In autoinflammatory syndromes with immunodeficiency, the “wiring” across these divisions can be faulty [1][2].
The Innate vs. Adaptive Overlap
Most people have heard of autoimmune diseases (like Lupus or Rheumatoid Arthritis), where the adaptive immune system (T-cells and B-cells) mistakenly learns to attack the body’s own healthy tissues, often using autoantibodies [3].
However, your diagnosis also involves autoinflammation. This largely involves the innate immune system—your body’s “first responders.” These cells do not need to “learn” to attack; they are born with sensors that detect danger [4]. In autoinflammatory conditions, these sensors may be too sensitive or the “off switches” (the brakes) are broken, leading to a constant state of fire and heat even when no germ is present [5]. This is not an either/or rule: real diseases often involve both branches overlapping. The “immunodeficiency” part means that while the inflammatory pathways are active, other protective functions (like producing antibodies) may be weak, leaving you vulnerable to infections [2][6].
The “Broken Brakes” and Overactive Pathways
Researchers have identified several key biological pathways that may go wrong in these syndromes. Two of the most important are NF-kB and the inflammasome.
- HA20 (The Lost Brake): This condition is caused by a mutation in the TNFAIP3 gene, which creates a protein called A20. Think of A20 as a primary “brake” for inflammation. It normally stops a powerful signaling messenger called NF-kB from causing too much swelling and fever [5][7]. When you have HA20, you don’t have enough A20 “brakes,” so the NF-kB signal can stay stuck in the “ON” position [8].
- APLAID (The Overactive Sensor): Caused by mutations in the PLCG2 gene, this condition can create an overactive enzyme. It acts like a hair-trigger sensor that floods your cells with calcium and inflammatory signals [6][9]. This immune dysregulation can also involve variable impairment of antibody production [6].
- HOIL-1 Deficiency (The Assembly Error): This involves a group of proteins called LUBAC that help build the immune system’s communication lines. When HOIL-1 is missing, the communication lines are built incorrectly. This may cause some cells to under-react to germs while others over-react and cause tissue damage [10][11].
Inherited vs. Acquired Mutations
One of the most important distinctions in your diagnosis is how the genetic change happened. This determines when the disease starts and how it might affect your family.
| Condition Type | Description |
|---|---|
| Germline (Inherited) Mutations | These are present in every cell of the body from birth. They are often passed down from a parent or happen spontaneously at conception. Conditions like HA20, APLAID, and HOIL-1 deficiency are usually germline and typically show symptoms in early childhood [5][10]. |
| Somatic (Acquired) Mutations | These are not inherited and cannot be passed to children. They happen later in life in a specific group of cells—usually the blood-forming cells in the bone marrow. VEXAS Syndrome is the most famous example. It is caused by a UBA1 mutation that most commonly appears in men over age 50 (though women and younger people can also be affected) [12][13]. |
Why This Isn’t “Standard” Immunodeficiency
In a typical primary immunodeficiency, the system is simply “quiet” or missing pieces. In your case, the system is “noisy” and chaotic. This “noise” (chronic inflammation) can overlap with autoimmune mechanisms and may further complicate your body’s ability to fight real infections [14]. Understanding the specific pathway involved—whether it’s the A20 brake or the LUBAC assembly line—is the first step toward finding targeted therapies that can attempt to quiet the noise [15].
Common questions in this guide
How are autoinflammation and autoimmunity different?
Why can these syndromes cause inflammation and infections at the same time?
What is HA20 and how does it affect inflammation?
What is the difference between a germline and a somatic mutation?
What do HA20, APLAID, and HOIL-1 deficiency have in common?
Is VEXAS syndrome inherited from a parent?
Can family members be tested for an autoinflammatory syndrome with immunodeficiency?
Get notified when new evidence is published on autoinflammatory syndrome with immunodeficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.
Aksentijevich I, Schnappauf O
Nature reviews. Rheumatology 2021; (17(7)):405-425 doi:10.1038/s41584-021-00614-1.
PMID: 34035534 - 2
Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency.
Magg T, Okano T, Koenig LM, et al.
Science immunology 2021; (6(60)) doi:10.1126/sciimmunol.abf9564.
PMID: 34145065 - 3
Autoinflammatory syndromes.
Meier-Schiesser B, French LE
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2021; (19(3)):400-426 doi:10.1111/ddg.14332.
PMID: 33620111 - 4
Perception of self: distinguishing autoimmunity from autoinflammation.
van Kempen TS, Wenink MH, Leijten EF, et al.
Nature reviews. Rheumatology 2015; (11(8)):483-92 doi:10.1038/nrrheum.2015.60.
PMID: 25963881 - 5
Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.
Zhou Q, Wang H, Schwartz DM, et al.
Nature genetics 2016; (48(1)):67-73 doi:10.1038/ng.3459.
PMID: 26642243 - 6
Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor.
Yang Z, Tao P, Han X, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2024; (76(11)):1670-1678 doi:10.1002/art.42948.
PMID: 38965708 - 7
The Ubiquitin System and A20: Implications in Health and Disease.
Mooney EC, Sahingur SE
Journal of dental research 2021; (100(1)):10-20 doi:10.1177/0022034520949486.
PMID: 32853526 - 8
Identification of a Novel Mutation in TNFAIP3 in a Family With Poly-Autoimmunity.
Rossi MN, Federici S, Uva A, et al.
Frontiers in immunology 2022; (13()):804401 doi:10.3389/fimmu.2022.804401.
PMID: 35154120 - 9
Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations.
Martín-Nalda A, Fortuny C, Rey L, et al.
Journal of clinical immunology 2020; (40(7)):987-1000 doi:10.1007/s10875-020-00794-7.
PMID: 32671674 - 10
Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia.
Boisson B, Laplantine E, Dobbs K, et al.
The Journal of experimental medicine 2015; (212(6)):939-51 doi:10.1084/jem.20141130.
PMID: 26008899 - 11
Linear Ubiquitin Code: Its Writer, Erasers, Decoders, Inhibitors, and Implications in Disorders.
Oikawa D, Sato Y, Ito H, Tokunaga F
International journal of molecular sciences 2020; (21(9)) doi:10.3390/ijms21093381.
PMID: 32403254 - 12
Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.
Beck DB, Ferrada MA, Sikora KA, et al.
The New England journal of medicine 2020; (383(27)):2628-2638 doi:10.1056/NEJMoa2026834.
PMID: 33108101 - 13
VEXAS syndrome.
Nakajima H, Kunimoto H
International journal of hematology 2025; (122(3)):341-350 doi:10.1007/s12185-024-03799-9.
PMID: 38819628 - 14
Type I interferon-mediated autoinflammation and autoimmunity.
Kretschmer S, Lee-Kirsch MA
Current opinion in immunology 2017; (49()):96-102 doi:10.1016/j.coi.2017.09.003.
PMID: 29128691 - 15
Evaluation and pilot testing of a multidisciplinary model of care to mainstream genomic testing for paediatric inborn errors of immunity.
Yanes T, Sullivan A, Barbaro P, et al.
European journal of human genetics : EJHG 2023; (31(10)):1125-1132 doi:10.1038/s41431-023-01321-z.
PMID: 36864115
This page is for informational purposes only and does not constitute medical advice. An immunologist or genetic counselor can help interpret your subtype, genetic results, and family implications.